Skip to main content
Top
Published in: Obesity Surgery 1/2020

01-01-2020 | Respiratory Microbiota | Original Contributions

Upregulation of Intestinal NLRP6 Inflammasomes After Roux-en-Y Gastric Bypass Promotes Gut Immune Homeostasis

Authors: Geng Wang, Qingbo Wang, Jie Bai, Ning Zhao, Yu Wang, Rui Zhou, Wen Kong, Tianshu Zeng, Kaixiong Tao, Guobin Wang, Zefeng Xia

Published in: Obesity Surgery | Issue 1/2020

Login to get access

Abstract

Objective

Roux-en-Y gastric bypass (RYGB) could affect immunological activity after surgery. We examined the role of RYGB on the NOD-like receptor pyrin domain containing-6 (NLRP6) in the intestine after surgery in rat models.

Methods

Expression of intestinal NLRP6 in the lean, obesity, RYGB, and sham-pair fed (PF) groups was analyzed by quantitative RT-PCR, Western blotting, and immunohistochemistry. Gut microbiota abundance was determined by 16S rRNA sequencing. Cohousing experiments were conducted to analyze the effects of gut microbiota. Inflammatory cell infiltration and gut permeability were further validated.

Results

Obese rats had decreased intestinal NLRP6 levels, which could be restored by RYGB but not by calorie restriction. This regulation was dependent on the gut microbiota-related metabolites, taurine, and histamine. After RYGB, there were increased levels of taurine, which could positively affect NLRP6 expression. The pair-fed groups showed increased histamine, which had the opposite effects on NLRP6. Obese rats had greater intestinal permeability along with increased CD8+ T cell infiltration. However, RYGB but not calorie restriction could restore these changes in a manner, dependent on gut NLRP6 expression.

Conclusions

In rat models, RYGB could efficiently restore abnormal gut permeability and reduce inflammation in the intestine, depending on reactivation of NLRP6.
Appendix
Available only for authorised users
Literature
1.
go back to reference Koch L. Surgery: T2DM remission after RYGB-a ‘gutsy’ move. Nat Rev Endocrinol. 2013;9(10):564.CrossRef Koch L. Surgery: T2DM remission after RYGB-a ‘gutsy’ move. Nat Rev Endocrinol. 2013;9(10):564.CrossRef
2.
go back to reference Korybalska K, Luczak J, Swora-Cwynar E, et al. Weight loss-dependent and -independent effects of moderate calorie restriction on endothelial cell markers in obesity. J Physiol Pharmacol. 2017;68(4):597–608.PubMed Korybalska K, Luczak J, Swora-Cwynar E, et al. Weight loss-dependent and -independent effects of moderate calorie restriction on endothelial cell markers in obesity. J Physiol Pharmacol. 2017;68(4):597–608.PubMed
3.
go back to reference Xia Z, Wang G, Li H, et al. Influence of bariatric surgery on the expression of nesfatin-1 in rats with type 2 diabetes mellitus. Curr Pharm Des. 2015;21(11):1464–71.CrossRef Xia Z, Wang G, Li H, et al. Influence of bariatric surgery on the expression of nesfatin-1 in rats with type 2 diabetes mellitus. Curr Pharm Des. 2015;21(11):1464–71.CrossRef
4.
go back to reference Guo Y, Liu CQ, Shan CX, et al. Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: Increased diversity and associations of discriminant genera with metabolic changes. Diabetes Metab Res Rev. 2017;33(3)CrossRef Guo Y, Liu CQ, Shan CX, et al. Gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in a diabetic rat model: Increased diversity and associations of discriminant genera with metabolic changes. Diabetes Metab Res Rev. 2017;33(3)CrossRef
5.
go back to reference Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3(3):207–15.CrossRef Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015;3(3):207–15.CrossRef
6.
go back to reference Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222(3):R113–27.CrossRef Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222(3):R113–27.CrossRef
7.
go back to reference Boulangé CL, Neves AL, Chilloux J, et al. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8(1):42.CrossRef Boulangé CL, Neves AL, Chilloux J, et al. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8(1):42.CrossRef
8.
go back to reference Dalmas E, Venteclef N, Caer C, et al. T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes. 2014;63(6):1966–77.CrossRef Dalmas E, Venteclef N, Caer C, et al. T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes. 2014;63(6):1966–77.CrossRef
9.
go back to reference Chen GY, Liu M, Wang F, et al. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol. 2011;186(12):7187–94.CrossRef Chen GY, Liu M, Wang F, et al. A functional role for Nlrp6 in intestinal inflammation and tumorigenesis. J Immunol. 2011;186(12):7187–94.CrossRef
10.
go back to reference Normand S, Delanoye-Crespin A, Bressenot A, et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci U S A. 2011;108(23):9601–6.CrossRef Normand S, Delanoye-Crespin A, Bressenot A, et al. Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci U S A. 2011;108(23):9601–6.CrossRef
12.
go back to reference Wang Q, Wang G, Hu C, et al. Optimization of a technique to standardize the rodent Roux-En-Y gastric bypass model and troubleshooting of postoperative failures. Obes Surg. 2019;29(5):1681–9.CrossRef Wang Q, Wang G, Hu C, et al. Optimization of a technique to standardize the rodent Roux-En-Y gastric bypass model and troubleshooting of postoperative failures. Obes Surg. 2019;29(5):1681–9.CrossRef
13.
go back to reference Hotz B, Arndt M, Dullat S, et al. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res. 2007;13(16):4769–76.CrossRef Hotz B, Arndt M, Dullat S, et al. Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res. 2007;13(16):4769–76.CrossRef
14.
go back to reference Rhee NA, Wahlgren CD, Pedersen J, et al. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. Diabetologia. 2015;58(10):2254–8.CrossRef Rhee NA, Wahlgren CD, Pedersen J, et al. Effect of Roux-en-Y gastric bypass on the distribution and hormone expression of small-intestinal enteroendocrine cells in obese patients with type 2 diabetes. Diabetologia. 2015;58(10):2254–8.CrossRef
15.
go back to reference Saeidi N, Meoli L, Nestoridi E, et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science. 2013;341(6144):406–10.CrossRef Saeidi N, Meoli L, Nestoridi E, et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science. 2013;341(6144):406–10.CrossRef
16.
go back to reference Mumphrey MB, Hao Z, Townsend RL, et al. Sleeve gastrectomy does not cause hypertrophy and reprogramming of intestinal glucose metabolism in rats. Obes Surg. 2015;25(8):1468–73.CrossRef Mumphrey MB, Hao Z, Townsend RL, et al. Sleeve gastrectomy does not cause hypertrophy and reprogramming of intestinal glucose metabolism in rats. Obes Surg. 2015;25(8):1468–73.CrossRef
17.
go back to reference Netto BD, Bettini SC, Clemente AP, et al. Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity. Obes Surg. 2015;25(6):1010–8.CrossRef Netto BD, Bettini SC, Clemente AP, et al. Roux-en-Y gastric bypass decreases pro-inflammatory and thrombotic biomarkers in individuals with extreme obesity. Obes Surg. 2015;25(6):1010–8.CrossRef
18.
go back to reference Mocanu AO, Mulya A, Huang H, et al. Effect of Roux-en-Y gastric bypass on the NLRP3 Inflammasome in adipose tissue from obese rats. PLoS One. 2015;10(10):e0139764.CrossRef Mocanu AO, Mulya A, Huang H, et al. Effect of Roux-en-Y gastric bypass on the NLRP3 Inflammasome in adipose tissue from obese rats. PLoS One. 2015;10(10):e0139764.CrossRef
19.
go back to reference Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179–88.CrossRef Vandanmagsar B, Youm YH, Ravussin A, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179–88.CrossRef
20.
go back to reference Pan F, Zhang L, Li M, et al. Predominant gut Lactobacillus murinus strain mediates anti-inflammaging effects in calorie- restricted mice. Microbiome. 2018;6(1):54.CrossRef Pan F, Zhang L, Li M, et al. Predominant gut Lactobacillus murinus strain mediates anti-inflammaging effects in calorie- restricted mice. Microbiome. 2018;6(1):54.CrossRef
21.
go back to reference Guo Y, Huang ZP, Liu CQ, et al. Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery. Eur J Endocrinol. 2018;178(1):43–56.CrossRef Guo Y, Huang ZP, Liu CQ, et al. Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery. Eur J Endocrinol. 2018;178(1):43–56.CrossRef
22.
go back to reference Elinav E, Strowig T, Kau AL, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145(5):745–57.CrossRef Elinav E, Strowig T, Kau AL, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145(5):745–57.CrossRef
23.
go back to reference Blanchard C, Moreau F, Chevalier J, et al. Sleeve gastrectomy alters intestinal permeability in diet-induced obese mice. Obes Surg. 2017;27(10):2590–8.CrossRef Blanchard C, Moreau F, Chevalier J, et al. Sleeve gastrectomy alters intestinal permeability in diet-induced obese mice. Obes Surg. 2017;27(10):2590–8.CrossRef
24.
go back to reference Levy M, Thaiss CA, Zeevi D, et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 Inflammasome signaling. Cell. 2015;163(6):1428–43.CrossRef Levy M, Thaiss CA, Zeevi D, et al. Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 Inflammasome signaling. Cell. 2015;163(6):1428–43.CrossRef
25.
go back to reference de La Serre CB, Ellis CL, Lee J, et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2010;299(2):G440–8.CrossRef de La Serre CB, Ellis CL, Lee J, et al. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 2010;299(2):G440–8.CrossRef
26.
go back to reference Anand PK, Malireddi RK, Lukens JR, et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature. 2012;488(7411):389–93.CrossRef Anand PK, Malireddi RK, Lukens JR, et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature. 2012;488(7411):389–93.CrossRef
27.
go back to reference Mamantopoulos M, Ronchi F, Van Hauwermeiren F, et al. Nlrp6- and ASC- dependent inflammasomes do not shape the commensal gut microbiota composition. Immunity. 2017;47(2):339–348.e4.CrossRef Mamantopoulos M, Ronchi F, Van Hauwermeiren F, et al. Nlrp6- and ASC- dependent inflammasomes do not shape the commensal gut microbiota composition. Immunity. 2017;47(2):339–348.e4.CrossRef
28.
go back to reference Wlodarska M, Thaiss CA, Nowarski R, et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell. 2014;156(5):1045–59.CrossRef Wlodarska M, Thaiss CA, Nowarski R, et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell. 2014;156(5):1045–59.CrossRef
29.
go back to reference Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177–85.CrossRef Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177–85.CrossRef
30.
go back to reference Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 2017;18(1):2.CrossRef Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 2017;18(1):2.CrossRef
31.
go back to reference Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15(8):914–20.CrossRef Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15(8):914–20.CrossRef
32.
go back to reference Sasaki T, Liu K, Agari T, et al. Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease. Exp Neurol. 2016;275(Pt 1):220–31.CrossRef Sasaki T, Liu K, Agari T, et al. Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease. Exp Neurol. 2016;275(Pt 1):220–31.CrossRef
33.
go back to reference Malek N, Kostrzewa M, Makuch W, et al. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. Pharmacol Res. 2016;111:251–63.CrossRef Malek N, Kostrzewa M, Makuch W, et al. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. Pharmacol Res. 2016;111:251–63.CrossRef
Metadata
Title
Upregulation of Intestinal NLRP6 Inflammasomes After Roux-en-Y Gastric Bypass Promotes Gut Immune Homeostasis
Authors
Geng Wang
Qingbo Wang
Jie Bai
Ning Zhao
Yu Wang
Rui Zhou
Wen Kong
Tianshu Zeng
Kaixiong Tao
Guobin Wang
Zefeng Xia
Publication date
01-01-2020
Publisher
Springer US
Published in
Obesity Surgery / Issue 1/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-04152-4

Other articles of this Issue 1/2020

Obesity Surgery 1/2020 Go to the issue